Our state-of-art facility houses a molecular biology department with highly qualified scientists to support and offer a wide range of services in the areas of recombinant DNA technology, antibody gene sequencing, mutagenesis, library generation, plasmid DNA preparation, microbial genome engineering, gene expression analysis, and IVT mRNA synthesis.
Antibody sequence information from hybridoma is essential for protecting, preserving, and optimizing monoclonal antibodies (mAbs). Antibody gene sequencing and reformatting at Aurigene is a one-stop solution for recombinant expression and production of antibodies. Our offering includes:
Our experienced team can support you wtih genome-scale modification of bacterial and yeast strains for the production of recombinant proteins, platform chemicals, and metabolic engineering.
Our clients have access to our cDNA, phage, and yeast libraries which we apply for high throughput screening and functional characterizations.
Regulation and expression of genes at transcriptional and translational stages play a crucial role in determining gene functions. We can carry out routine expression studies by several methods including:
Residual host-cell proteins (HCP) and host-cell DNA (HCD) are impurities in recombinant biotherapeutics, which need to be detected and quantified to prove that they meet the limits set by global regulatory agencies. To do that, we apply the following methods:
Aurigene Pharmaceutical Services is
provides the best contract research manufacturing
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.